Jeonju, South Korea

Ok Ja Choi

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Korea Atomic Energy Research Institute. Active years: 2010.



Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Ok Ja Choi in Medical Imaging

Introduction

Ok Ja Choi is a notable inventor based in Jeonju, South Korea. He has made significant contributions to the field of medical imaging through his innovative work on DTPA derivatives and metal complexes. His inventions are particularly relevant for enhancing diagnostic techniques in renal function assessment.

Latest Patents

Ok Ja Choi holds a patent for "DTPA derivatives and metal complexes thereof, and radiation source and contrast agent including the metal complexes." This invention relates to diethylenetriamine pentaacetic acid (DTPA) derivatives that contain iodine, which are useful as contrast agents for diagnosing renal function. The patent also covers metal complexes of these DTPA derivatives, which can be utilized as liquid radiation sources for treating vascular stenosis. The safety and cost-effectiveness of these metal complexes make them valuable in both medical imaging and treatment applications.

Career Highlights

Choi is affiliated with the Korea Atomic Energy Research Institute, where he continues to advance research in medical imaging technologies. His work has garnered attention for its potential to improve patient outcomes through enhanced diagnostic capabilities.

Collaborations

Choi collaborates with esteemed colleagues, including Young-Don Hong and Sun-Ju Choi, who contribute to the research and development of innovative medical solutions.

Conclusion

Ok Ja Choi's contributions to the field of medical imaging through his patented inventions demonstrate the importance of innovation in healthcare. His work not only enhances diagnostic techniques but also ensures patient safety and cost-effectiveness in medical treatments.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…